Barco contributes to PathPresenter investment round, to accelerate adoption of digital pathology workflows

The commercial partnership aims at enabling and accelerating adoption of digital pathology, leveraging both companies’ ecosystems and channels, and developing joint end-to-end offerings across the various use cases in this rapidly evolving segment.

For Barco, the investment confirms our commitment to the digital pathology segment – acknowledging our intention to create superior end-user value through our visualization solutions and applications.

PathPresenter: image sharing platform for pathology

PathPresenter’s enterprise platform empowers top-tier hospitals, labs, and pharmaceutical companies to create seamless digital pathology workflows. By connecting institutions and pathologists globally, the platform leverages 3rd party AI algorithms and foundational models to enhance patient outcomes and create new profit centers from digital pathology investments.

Supporting the digital pathology transformation worldwide

Founded by dermatopathologist and digital pathology pioneer Dr. Rajendra Singh, PathPresenter began as a free online platform and rapidly became the world’s largest and fastest-growing digital pathology community with more than 50,000 users in 172 countries, and a thriving enterprise platform across clinical, research and educational workflows.

The funds from the Series A will be used by PathPresenter to advance the features and interoperability of the vendor-agnostic platform, invest in talent across engineering and commercial functions, and accelerate the achievement of regulatory milestones.

By adding our Barco expertise in medical visualization technology to this investment, we’re excited to continue innovating the digital viewing experience for pathologists worldwide!

Read more in the press release by PathPresenter.